Phase 1 Ovarian Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older.
- People whose tumor tests positive for a protein called CLDN6.
- People who have been diagnosed (through tissue or cell testing) with a specific type of advanced, returning, or spread ovarian cancer called high grade serous ovarian carcinoma (HGSOC), which may also include cancers starting in the fallopian tubes or the lining of the abdomen.
- People whose general physical health and ability to carry out daily activities meets a certain standard, as assessed by their doctor using a recognised medical scale (confirm with trial site).
- People with a life expectancy of at least 3 months.
- People whose organs (such as kidneys, liver, and heart) are functioning well enough to meet the trial's requirements (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously received a treatment that targets the CLDN6 protein using a type of therapy called an immune cell engager.
- People who have brain metastases (cancer that has spread to the brain) that have not been treated, or that are not considered stable on scans after treatment.
- People with an active autoimmune disease (a condition where the immune system attacks the body) that is known or suspected.
- People who have needed ongoing medication such as corticosteroids or other drugs that suppress the immune system within the 14 days before the first dose of the trial treatment.
- People with serious heart, lung, or digestive system conditions.
- People with an active hepatitis B or hepatitis C viral infection.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Adverse Events; Incidence of dose-limiting toxicities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.